D
iabetes-induced vision loss is a massive health care problem in the United States and around the world. The problem is becoming worse with the increasing prevalence of obesity. By 2050, the number of Americans with diabetic retinopathy is projected to triple from 5.5 million to 16 million, and visionthreatening retinopathy is projected to increase from 1.2 million to 3.4 million. 1 The only proven medical therapy for diabetic retinopathy is control of blood glucose level and blood pressure, so it is crucial for ophthalmologists to identify patients at risk. 2 In many cases the "ABCs" (hemoglobin A1c [HbA 1c ] level, blood pressure values, and low-density lipoprotein cholesterol [LDL-C] levels) are not communicated between ophthalmologists and other primary care physicians, so patient understanding of these risk factors is crucial for proper management. Do et al 3 investigated awareness of HbA 1c , but to our knowledge no study has assessed all 3 levels. Therefore, the rationale for this study is to determine the proportion of ophthalmology patients with diabetes who know personal and recommended ABCs of diabetes care.
Methods.
A standardized survey was created for adult participants with diabetes mellitus to investigate their knowledge of personal and recommended ABCs of diabetes care. The recommended levels were as follows based on the recommendations from the American Diabetes Association and national expert committees and panels: HbA 1c , less than 7.0%; blood pressure, lower than 130/80 mm Hg; and LDL-C levels, less than 100 mg/dL (to convert to millimoles per liter, multiply by 0.0259). [4] [5] [6] The study was conducted between May 13, 2009, and July 22, 2009, at the Penn State Hershey Ophthalmology outpatient clinic. All patients who were aged 18 years or older, had a diagnosis of type 1 or type 2 diabetes mellitus, and were seen at the ophthalmology clinic were eligible for inclusion in the study. Exclusion criteria included being younger than 18 years, not having a diagnosis of diabetes mellitus, and having mental impairment. Surveys were completed verbally by the same investigator (C.D.) to ensure consistency and include persons with visual impairment.
Results.
After asking 166 patients with diabetes to participate, a total of 161 participants were enrolled in the study. There were 72 male participants (45%) and 89 female participants (55%). The mean age was 61.7 years, with an age range from 19 to 89 years. The Table demonstrates the numbers of participants with self-reported knowledge of personal and recommended levels of HbA 1c , blood pressure, and LDL-C. When combined, only 7 patients (4%) reported meeting the recommendation for all 3 of the ABCs of diabetes care and 10 patients (6%) reported knowing all 3 recommendations. These rates increased to 38 patients (23%) and 64 patients (40%), respectively, for those surveyed who reported meeting and knowing at least 2 of the 3 recommendations.
Comment.
The major finding of this study is that only 4% of persons with diabetes reported meeting the therapeutic goals for the major risk factors for diabetes complications. This demonstrates the lack of patient knowledge regarding the relationship between systemic risk factors and diabetic eye disease. While more than those described were most likely meeting the recommended goals, the numbers obtained closely mirror those of a recent study in which only 7.3% of diabetic patients met the same 3 therapeutic goals. 7 Ophthalmologists have a unique opportunity to influence patient behavior because the loss of vision is one of the most feared complications of diabetes. One way of helping could be the implementation of a "know your numbers" card on which the recent HbA 1c , blood pressure, and LDL-C values are recorded and kept by the patient. This card could be reviewed by the patient's ophthalmologist, primary care physician, and other physicians. This tool would allow better coordination between physicians and reinforce goals to patients with diabetes. Such a simple tool could serve as an inexpensive, yet tangible means for ophthalmologists to educate patients and decrease the risk of vision loss from diabetic retinopathy using established medical practice guidelines. 
COMMENTS AND OPINIONS Evisceration Is Useful in Certain Situations

R
egarding the article by Eagle et al, 1 we would like to make 2 comments. (1) All 7 cases presented in the article represent incomplete evaluations and questionable decision making and should not serve to discourage evisceration from being offered as a useful option for some patients. ( 2) The concluding paragraph is unnecessarily absolutist. With appropriate evaluation and in the proper situation, evisceration is an important surgical tool and should not be labeled "unconscionable" or eliminated from the ophthalmic surgical repertoire.
In reviewing the 7 cases presented, only 1 of the 7 cases had a preoperative ultrasound, and 3 of the 7 had no preoperative imaging at all. The patient in case 1 had an evisceration despite computed tomographic (CT) imaging that showed choroidal thickening, and "the posterior choroidal thickening was disregarded" by the surgeon. The patient in case 4 had an evisceration despite a CT scan showing a large intraconal orbital tumor and hyperintensity of the intraocular contents suggesting a mass. The patient in case 6 was known to have ocular melanoma that was previously treated with radiation, and yet had an evisceration. In case 5, the ocular ultrasound showed an intraocular mass that was misinterpreted as vitreous hemorrhage. In case 7, a CT scan showed an intraocular mass that was misinterpreted because the melanoma filled the entire vitreous cavity and contrast was not used, nor was ultrasound performed. The patients in cases 2 and 3 were not imaged preoperatively in any way-clearly not the standard of care.
On the subject of evisceration in the context of endophthalmitis, we agree with Eagle et al that enucleation is a good option. A landmark study published in 1987 2 reviewed 219 cases between 1950 and 1987 and concluded that, since the advent of antibiotics, enucleation is not contraindicated in cases of endophthalmitis. Indeed, their study failed to reveal a single case of postenucleation meningitis of 165 enucleations performed. We both have performed enucleations in the setting of endophthalmitis with no negative sequelae, and the greater ophthalmic community should be better educated on this issue.
We believe that evisceration is a useful technique in some situations, and represents anywhere from 14% to 57% of all eye removal procedures reported during the past decade. [3] [4] [5] [6] [7] [8] [9] As long as a complete evaluation is performed to rule out an intraocular tumor, including a posterior segment ultrasound and possibly a CT scan when the posterior pole cannot be visualized, evisceration should be available as an option for surgeons and patients. We agree with Eagle et al that in the absence of proper ophthalmic evaluation, including imaging, evisceration should be avoided. Also, in any case in which the evaluation data are suspicious or an intraocular tumor cannot clearly be distinguished from confusing lesions such as hemorrhage, evisceration should not be performed. 
